Treatments

Cancer and Organ Transplant Clinic

The Cancer and Organ Transplant Clinic (COTC) at Seattle Cancer Care Alliance (SCCA) is the first clinic of its kind to offer consulting services for organ transplant candidates and recipients with cancer. SCCA works together with UW Medicine Transplant Services to tackle the challenging conditions experienced by patients with cancer before and after an organ transplant.

Coordinated care from cancer and transplant specialists

At the COTC, cancer and organ transplant specialists work together to treat patients based on their cancer type and transplant condition, current treatments and any off-target effects, biomarkers, comorbidities, general health and life goals.

SCCA works with the National Collaborative Cancer & Transplant Bioregistry, SCCA/Fred Hutch and UW Medicine to study patient-centered questions.

Solving transplant challenges

Cancer can threaten organ health, and organ transplant can improve the health of some cancer patients. The COTC aims to make transplant an option for more cancer patients. If you become a patient in our clinic, you will:

  • Meet with cancer and transplant specialists to receive a personalized treatment plan
  • Receive care focused on your specific cancer and transplant challenges
  • Work with our dedicated intake team for referral to the appropriate transplant clinic, if needed
  • Work with recovery teams who collaborate across specialties to get you back to living your life

Organ transplant designed for patients with specific cancers

SCCA offers kidney, pancreas, heart and lung transplant services for patients with many different types of cancers:
 

About our clinic

We started the COTC to answer the questions that make it challenging for patients to receive and maintain organ transplant function:

  • When is it safe for an organ transplant after cancer treatment?
  • What are the best cancer therapies to achieve optimal cancer response and transplant function?
  • What are the best cancer therapies that set up a patient to be an organ transplant recipient in the future?
  • How can transplant-focused immunosuppression be used to eliminate rejection issues for organ transplant patients?

Care team

Meet the caring, dedicated people who take care of you and your family at SCCA.

Christopher D. Blosser, MD
Christopher D. Blosser, MD
Physician
Nephrology
Laura S. Connelly-Smith, MBBCh, DM
Laura S. Connelly-Smith, MBBCh, DM
Physician
Medical Oncology
Andrew J. Cowan, MD
Andrew J. Cowan, MD
Physician
Medical Oncology
Evan T. Hall, MD, MPhil
Evan T. Hall, MD, MPhil
Physician
Medical Oncology
Josiah  Hanson, MD
Josiah Hanson, MD
Physician
Dermatology
Sarah S. Lee, MD
Sarah S. Lee, MD
Physician
Medical Oncology
Cristina  Merkhofer, MD, MHS
Cristina Merkhofer, MD, MHS
Physician
Medical Oncology
Linda S.  Mihalov, MD, FACOG
Linda S. Mihalov, MD, FACOG
Physician
Gynecology
Christina  Poh, MD
Christina Poh, MD
Physician
Medical Oncology
Sarah  Psutka, MD
Sarah Psutka, MD
Physician
Surgery
George R. Schade, MD
George R. Schade, MD
Physician
Surgery
John A. Thompson, MD
John A. Thompson, MD
Physician
Medical Oncology
Vyshak  Venur, MD
Vyshak Venur, MD
Physician
Medical Oncology
Todd  Yezefski, MD, MS
Todd Yezefski, MD, MS
Physician
Medical Oncology